A.MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Name and address of the manufacturer responsible for batch release
65926 Frankfurt am Main Germany
- Taxespira (docetaxel hospira uk limited ) - docetaxel trihydrate
- Docetaxel teva pharma - docetaxel
- Docetaxel kabi - docetaxel
- Docetaxel accord - docetaxel
- Docetaxel mylan - docetaxel, anhydrous
Prescription drugs listed. Substance: "Docetaxel"
(Harbor Park) 1, Campona utca Budapest 1225
The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.
B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORIZATION
•Periodic Safety Update Reports
The marketing authorisation holder shall submit periodic safety update reports for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) ) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines
D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
•Risk Management Plan (RMP)
•Obligation to conduct